ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Exploring financial toxicity and its impact on health-related quality of life of cancer patients.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Examining the relationships between financial toxicity, life satisfaction, and quality of life levels in older adult cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Oncologists' insights and solutions on navigating financial toxicity: an exploratory study in Pakistan.BMJ open · 2026Article
- Article
- Article
- Step forward: how health insurance mitigates financial toxicity in cancer care in Pakistan.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study evaluates financial toxicity (FT), its risk factors and assesses its relationship with health-related quality of life (HRQOL) in cancer patients in Bahawalpur, Pakistan.
methodThis was a cross-sectional study of cancer patients undergoing treatment in two public hospitals. It assessed FT with a Comprehensive Score for Financial Toxicity (COST) and HRQOL with a functional assessment of cancer therapy: general (FACT-G). A questionnaire was also utilised to collect and analyse data. We conducted a linear regression analysis to identify risk factors for FT and Pearson correlation to evaluate the association between FT and HRQOL.
resultsThe study included 336 patients between March and June 2024. The majority of the patients were female and from rural areas. The mean COST score was 7.21 (2-12), and the mean FACT-G score was 28.60 (22-37). There was a strong positive relationship between the COST and FACT-G scores, indicated by a correlation coefficient of 0.84 (P < 0.001). Furthermore, the study observed that the COST score was a reliable predictor of the FACT-G score. Multivariate linear regression analysis found cancer type (β = - 0.346; 95% CI, - 0.588 to - 0.103; P < 0.05), residence (β = - 0.494; 95% CI, - 1.005 to 0.017; P < 0.05), and distance between home and healthcare facility (β = - 0.340; 95% CI, - 0.607 to - 0.073; P < 0.05) as risk factors of the FT.
conclusionsOur findings indicate high FT, underscoring the critical need for strategies to reduce the growing FT among cancer patients in Pakistan. Moreover, the significant relationship between FT and HRQOL needs further studies to explore potential causal factors.
Indexed as
Identifiers
40100286What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.